ScreenerHero
ILM1Medios AG
XETRA · DE · Healthcare · Medical Distribution · medios.ag
10.98EUR+0.92%Mkt Cap: 301.63M $P/E: 23.65

Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. …

Industry Peers

Medical Distribution
Screen all
MCK
McKesson Corporation
$99.53BUSDP/E 22.9
COR
CoreSite Realty Corporation
$60.51BUSDP/E 23.5
CAH
Cardinal Health, Inc.
$54.62BUSDP/E 32.4
HSIC
Henry Schein, Inc.
$10.17BUSDP/E 26.0
GALE
Galenica AG
$4.70BUSDP/E 25.6
SELEC
Selcuk Ecza Deposu Ticaret ve Sanayi A.S.
$4.22BUSDP/E 79.3
AMP
Amplifon S.p.A.
$3.42BUSDP/E 38.2
ASKER
Asker Healthcare Group AB
$2.81BUSDP/E 43.1
UPR
Uniphar plc
$1.17BUSDP/E 20.7
ARJO-B
Arjo AB (publ)
$747.71MUSDP/E 20.2
M12
M1 Kliniken AG
$371.48MUSDP/E 15.3
BLC
Bastide Le Confort Médical SA
$182.73MUSDP/E 18.3
MLFMV
Farminveste, S.G.P.S., S.A.
$115.23MUSD
ACH
Aluminum Corporation of China Limited
$101.51MUSD
NAVA
Navamedic ASA
$34.63MUSD
RMAH
Farmaceutica REMEDIA S.A.
$18.14MUSDP/E 11.1
ALEMG
Laboratoires Euromedis Société anonyme
$15.40MUSD
WGRX
Wellgistics Health Inc. Common Stock
$8.85MUSD
MEDS
Trxade Group, Inc.
$4.38MUSD
MLMIB
Metrics in Balance N.V.
$157.5KUSD

Key Statistics

Company
Market Cap301.63M $
Enterprise Value415.44M $
Revenue (TTM)2.35B $
Gross Profit216.49M $
Net Income (TTM)16.70M $
Revenue/Share95.72 USD
Last Price10.98 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees989
CountryDE
SectorHealthcare
IndustryMedical Distribution
ISINDE000A1MMCC8
Valuation
P/E (Trailing)23.65
P/E (Forward)6.96
PEG—
EV/EBITDA5.48
EV/Revenue0.18
P/S0.13
P/B0.51
EPS (TTM)0.46
EPS (Forward)1.57
52W Range
10.803% of range17.44
52W High17.44 EUR
52W Low10.80 EUR
Profitability
Gross Margin9.58%
Oper. Margin1.64%
EBITDA Margin3.22%
Profit Margin0.74%
ROE2.99%
ROA1.70%
Growth
Revenue Growth8.00%
Earnings Growth-41.50%
Cash Flow & Leverage
Operating CF56.82M $
CapEx (TTM)9.01M $
FCF Margin1.06%
FCF Yield8.30%
Net Debt125.48M $
Net Debt/EBITDA1.66
Balance Sheet
Debt/Equity0.37
Current Ratio1.84
Quick Ratio1.30
Book Value/Sh21.20 EUR
Cash/Share3.450 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:4
Split DateJul 19, 2012
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)21.00 EUR
Upside (mean)+91.3%
Target Range16.00 EUR – 25.00 EUR
€16.00+91.3% to mean€25.00
# Analysts4
Ownership
Shares Out.25.51M
Float8.34M
Insiders19.70%
Institutions48.00%
Technical
SMA 5011.90 (-7.8%)
SMA 20013.71 (-19.9%)
Beta1.29
S&P 52W Chg18.16%
Avg Vol (30d)37.15K
Avg Vol (10d)40.19K
Technical Indicators
RSI (14)35.2
MACD-0.3056
MACD Signal-0.3074
MACD Hist.+0.0018
BB Upper12.42 EUR
BB Middle11.34 EUR
BB Lower10.27 EUR
BB Width18.89%
ATR (14)0.3710 EUR
Vol Ratio (20d)0.27x